Biochemistry
Polymer-Based Chemo-Immunotherapy Shows Promise in Treating Melanoma
Researchers from the University of Utah have made a groundbreaking discovery in the field of oncology, specifically in the treatment of melanoma. They have developed a polymer-based chemo-immunotherapy strategy that combines immune checkpoint inhibitor (ICI) monotherapy with a multivalent HPMA copolymer-peptide antagonist of PD-L1 (PPA). This innovative approach has shown